Back
Microsoft Corp. Vs. Akero Therapeutics, Inc. Industry Stock Comparison
Sell
39
MSFT
Microsoft Corp.
Last Price:
$476.25
Seasonality Move:
5.2%
Buy
55
AKRO
Akero Therapeutics, Inc.
Last Price:
$54.65
Seasonality Move:
10.37%
Sell
39
Microsoft Corp. (MSFT)
is a Sell
Is Microsoft Corp. a Buy, Sell or Hold?
-
The current Microsoft Corp. [MSFT] share price is $474.82. The Score for MSFT is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
-
MSFT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
55
Akero Therapeutics, Inc. (AKRO)
is a Buy
Is Akero Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Akero Therapeutics, Inc. [AKRO] share price is $54.65. The Score for AKRO is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
-
AKRO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
MSFT Stock Price Chart
What is Microsoft Corp.'s stock price today?
-
The Microsoft Corp. share price today is $474.82Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MSFT is experiencing slight selling pressure.
AKRO Stock Price Chart
What is Akero Therapeutics, Inc.'s stock price today?
-
The Akero Therapeutics, Inc. share price today is $54.65Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AKRO is experiencing slight buying pressure.
MSFT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -6.51 | Sell |
| Relative Strength Index (14 RSI): | 39.53 | Sell |
| Chaikin Money Flow: | -10417848 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (476.83 - 501.07) | Sell |
| Bollinger Bands (100): | (493.01 - 523.77) | Sell |
AKRO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.34 | Buy |
| Relative Strength Index (14 RSI): | 69.15 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (54.26 - 54.6) | Buy |
| Bollinger Bands (100): | (46.52 - 54.32) | Buy |
MSFT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 482.8 | Sell |
| 20-day SMA: | 484.22 | Sell |
| 50-day SMA: | 503.82 | Sell |
| 200-day SMA: | 472.29 | Buy |
| 8-day EMA: | 481.47 | Sell |
| 20-day EMA: | 486.94 | Sell |
| 50-day EMA: | 496.79 | Sell |
| 200-day EMA: | 480.69 | Sell |
AKRO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 54.64 | Buy |
| 20-day SMA: | 54.48 | Buy |
| 50-day SMA: | 53.7 | Buy |
| 200-day SMA: | 48.36 | Buy |
| 8-day EMA: | 54.62 | Buy |
| 20-day EMA: | 54.42 | Buy |
| 50-day EMA: | 53.21 | Buy |
| 200-day EMA: | 47.82 | Buy |
Microsoft Corp. Earnings Growth & MSFT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.63 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.59 per share, and an increase next year of $2.81 per share.
Akero Therapeutics, Inc. Earnings Growth & AKRO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.25 per share, and a decrease next year of $0.32 per share.
Microsoft Corp. Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Akero Therapeutics, Inc. Technical Analysis
| Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||